Back to Search
Start Over
Two‐year crizotinib monotherapy induced durable complete response of pediatric ALK‐positive inflammatory myofibroblastic tumor.
- Source :
- Pediatric Blood & Cancer; Aug2023, Vol. 70 Issue 8, p1-3, 3p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 15455009
- Volume :
- 70
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Pediatric Blood & Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 164487403
- Full Text :
- https://doi.org/10.1002/pbc.30330